The dramatic decline in annual HIV infections has stopped and new infections have stabilized in recent years, according to a CDC report published today.
A new way to create proteins that can sneak through HIV's protective coating may be a step toward understanding the key components needed for developing a vaccine for the virus, according to researchers.
New HIV infections in the United States could be substantially reduced by up to 67 percent by 2030 if ambitious goals for HIV care and treatment are met and targeted prevention interventions for people at risk for HIV are rapidly scaled up, according to a study by Georgia State University and the
In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus's outer envelope where a lineage of antibodies are able to dock and neutralize the virus.
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy.
NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients
The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States.
Deepak Kaushal, PhD, director of the Southwest National Primate Research Center, says research he collaborated on is pinpointing a possible new avenue of protection for HIV/AIDS patients.
Every county in the United States tracks HIV cases, sequencing the virus’ genome to see if it is resistant to current medications and looking for trends.
It's long been known that couples HIV testing and counseling is an effective way to mutually disclose HIV status and link to health care--unfortunately, couples don't use it even though it's widely available.